CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES

CCTN-避孕发展计划-NICHD避孕临床试验网络-女性站点-核心功能活动

• 批准号: 10897676
• 负责人: BEATRICE CHEN, M.D., MPH
• 金额: $ 0.15万
• 依托单位: MAGEE-WOMEN'S RES INST AND FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-01 至 2024-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10897676
• 关键词: Clinical Trials Network; Conduct Clinical Trials; Contraceptive Agents; Contraceptive methods; Development; Female; Future; Goals; Medical; Methods; Mission; National Institute of Child Health and Human Development; Obesity; Program Development; Protocols documentation; Risk Reduction; Services; Site; Woman; product development; protocol development; unintended pregnancy; venous thromboembolism

There is a demand for new methods of contraception that can provide effective protection against unintended pregnancy as well as reduce the risk of venous thromboembolism (VTE), particularly for obese women. The mission of the Contraceptive Clinical Trials Network (CCTN) is to develop protocols and conduct clinical trials that will assist in product development with the end goal to provide effective and safe contraception for women. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has a mission to develop safe and effective contraceptives for women, including obese women and women who have medical conditions for which current contraceptive products are contraindicated.

人们需要新的避孕方法，以有效防止意外怀孕并降低静脉血栓栓塞的风险 （VTE），特别是对于肥胖女性。避孕临床试验网络 (CCTN) 的使命是制定方案并进行临床试验，以协助产品开发，最终目标是为女性提供有效、安全的避孕方法。 尤尼斯·肯尼迪·施赖弗国家儿童健康和人类发展研究所 (NICHD) 的使命是为女性开发安全有效的避孕药具，其中包括肥胖女性和患有当前避孕产品禁忌症的女性。